Akorn, Inc., a leading specialty pharmaceutical company, today announced that the United States Bankruptcy Court for the District of Delaware has approved its sale to the Company’s existing lenders. Akorn is working to finalize customary closing obligations and anticipates the sale will be completed in the next few weeks.
Read the full article: Akorn Receives Court Approval of Sale to Lenders //
Source: https://www.prnewswire.com/news-releases/akorn-receives-court-approval-of-sale-to-lenders-301122975.html